Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

FORGOTTEN HISTORY: Casi pharmaceuticals s return on capital employed insights ecc13d7b 0aa8 4b6b b68e 190644d51bfb | History Defined

Benzinga Pro data, CASI Pharmaceuticals (NASDAQ:CASI) reported Q1 sales of $9.06 million. Earnings fell to a loss of $8.40 million, resulting in a 55.7% decrease from last quarter. CASI Pharmaceuticals collected $9.16 million in revenue during Q4, but reported earnings showed a $5.39 million loss.

What Is Return On Capital Employed?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.